Bengaluru, India

Gopikishan Tonukunuru

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 10.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Gopikishan Tonukunuru: Innovator in Pharmaceutical Compounds

Introduction

Gopikishan Tonukunuru is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that activate T cells. With a total of five patents to his name, his work is paving the way for advancements in medical treatments.

Latest Patents

Among his latest patents, Gopikishan has developed substituted naphthyridinone compounds that are useful as T cell activators. These compounds are designed to inhibit the activity of diacylglycerol kinase alpha (DGKα) and diacylglycerol kinase zeta (DGKζ). The pharmaceutical compositions comprising these compounds are particularly useful in treating viral infections and proliferative disorders, such as cancer.

Career Highlights

Gopikishan currently works at Bristol-Myers Squibb Company, where he continues to innovate in the pharmaceutical sector. His research focuses on creating effective treatments that can significantly impact patient care and outcomes.

Collaborations

He collaborates with talented coworkers, including Jayakumar Sankara Warrier and Hasibur Rahaman, who contribute to his research and development efforts.

Conclusion

Gopikishan Tonukunuru is a prominent figure in the field of pharmaceutical innovations, with a focus on T cell activation compounds. His work is essential in the ongoing fight against viral infections and cancer, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…